SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Akoustis Technologies, Inc. 
 NC
  SEC # 1584754


        
1  Related Registrant:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

233  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
1/29/24424B51About This Prospectus
1About This Prospectus Supplement
9/18/23DEF 14A1Annual Report
1/29/24424B51Applicable prospectus supplement or free writing prospectus may describe, The
9/18/23DEF 14A1Board Leadership Structure and Role in Risk Oversight
1Board Meetings and Director Attendance
9/6/2310-K1Business
1/29/24424B51Capitalization
1Cautionary Note Regarding Forward-Looking Information
1Certain Provisions of Delaware Law and of the Company's Certificate of Incorporation and Bylaws
9/18/23DEF 14A1Certain Relationships and Related Person Transactions
9/6/2310-K1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
9/18/23DEF 14A1Code of Business Conduct and Ethics
1Committees of the Board of Directors
1/29/24424B51Company, The
9/18/23DEF 14A1Compensation and Other Information Concerning Our Executive Officers and Directors
2/13/2410-Q1Condensed Consolidated Balance Sheets as of December 31, 2023 and June 30, 2023 (unaudited)
5/8/2310-Q1Condensed Consolidated Balance Sheets as of March 31, 2023 and June 30, 2022 (unaudited)
11/13/2310-Q1Condensed Consolidated Balance Sheets as of September 30, 2023 and June 30, 2023 (unaudited)
5/8/2310-Q1Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2023 and 2022 (unaudited)
2/13/2410-Q1Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2023 and 2022 (unaudited)
11/13/2310-Q1Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2023 and 2022 (unaudited)
5/8/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended March 31, 2023 and 2022 (unaudited)
2/13/2410-Q1Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and six months ended December 31, 2023 and 2022 (unaudited)
11/13/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Equity for the three months ended September 30, 2023 and 2022 (unaudited)
5/8/2310-Q1Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2023 and 2022 (unaudited)
2/13/2410-Q1Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2023 and 2022 (unaudited)
11/13/2310-Q1Condensed Consolidated Statements of Operations for the three months ended September 30, 2023 and 2022 (unaudited)
9/6/2310-K1Consolidated Balance Sheets
1Consolidated Balance Sheets as of June 30, 2023 and 2022
1Consolidated Statement of Changes in Stockholders' Equity for the years ended June 30, 2023 and 2022
1Consolidated Statements of Cash Flows
1Consolidated Statements of Cash Flows for the years ended June 30, 2023 and 2022
1Consolidated Statements of Changes in Stockholders' Equity
1Consolidated Statements of Operations
1Consolidated Statements of Operations for the years ended June 30, 2023 and 2022
2/13/2410-Q1Controls and Procedures
9/18/23DEF 14A1Corporate Governance Matters
1Date, Time, and Place
2/13/2410-Q1Defaults Upon Senior Securities
9/18/23DEF 14A1DELINQUENT SECTION 16(a) REPORTS
1/29/24424B51Description of Common Stock We May Offer
1Description of Debt Securities and Guarantees We May Offer
1Description of Preferred Stock We May Offer
1Description of Rights We May Offer
1Description of Units We May Offer
1Description of Warrants We May Offer
1Dilution
9/18/23DEF 14A1Director Compensation
1Director Independence
1Directors and Executive Officers
9/6/2310-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions that Prevent Inspection
9/18/23DEF 14A1Executive Compensation
2/13/2410-Q1Exhibit Index
1Exhibits
9/6/2310-K1Exhibits and Financial Statement Schedules
1/29/24424B51Experts
9/18/23DEF 14A1Fees
2/13/2410-Q1Financial Information
1Financial Statements
9/6/2310-K1Financial Statements and Supplemental Data
1/29/24424B51Forward-Looking Statements
9/18/23DEF 14A1General Information Concerning Voting
1Householding of Annual Meeting Materials
1/29/24424B51Incorporation by Reference
1Incorporation of Certain Documents by Reference
9/6/2310-K1Industry and the markets in which the Company operates are highly competitive and subject to rapid technological change, The
1/29/24424B51Legal Matters
2/13/2410-Q1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
9/6/2310-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity Securities
1/29/24424B51Material U.S. Federal Income Tax Considerations to Non-U.S. Holders
2/13/2410-Q1Mine Safety Disclosures
9/6/2310-K1Notes to Consolidated Financial Statements
2/13/2410-Q1Notes to the Condensed Consolidated Financial Statements (unaudited)
1Other Information
9/18/23DEF 14A1Other Matters
9/6/2310-K1Part I
2/13/2410-Q1Part I -- Financial Information
9/6/2310-K1Part Ii
2/13/2410-Q1Part Ii -- Other Information
9/6/2310-K1Part Iii
1Part Iv
1/29/24424B51Plan of Distribution
11/13/23S-81Power of Attorney (included on the signature page of this Registration Statement)
9/18/23DEF 14A1Pre-Approval Practice
9/6/2310-K1Principal Accountant Fees and Services
9/18/23DEF 14A1Process for Nominating Potential Director Candidates
9/6/2310-K1Properties
9/18/23DEF 14A1Proposal 1 Election of Directors
1Proposal 2 Advisory Vote on Executive Compensation
1Proposal 3 Amendment to Certificate of Incorporation to Increase Authorized Shares
1Proposal 4 Amendment to Employee Stock Purchase Plan
1Proposal 5 Ratification of the Independent Registered Public Accounting Firm for the Fiscal Year Ending June 30, 2024
1/29/24424B51Prospectus Supplement Summary
9/18/23DEF 14A1Purpose of the Annual Meeting
2/13/2410-Q1Quantitative and Qualitative Disclosures About Market Risk
9/18/23DEF 14A1Quorum and Vote Necessary for Action
1Recommendation of the Board of Directors
1References to Our Website Address
9/6/2310-K1Report of Independent Registered Public Accounting Firm PCAOB ID# 688
9/18/23DEF 14A1Report of the Audit Committee
9/6/2310-K1Reserved
9/18/23DEF 14A1Revocability of Proxies
2/13/2410-Q1Risk Factors
9/18/23DEF 14A1Security Ownership of Certain Beneficial Owners and Management
9/6/2310-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
2/13/2410-Q1Signatures
9/18/23DEF 14A1Stockholder and Interested Party Communications with Directors
1Submission of Future Stockholder Proposals and Nominations
1Submitting a Proxy
1Table of Contents
1/29/24424B51The applicable prospectus supplement or free writing prospectus may describe
1The Company
9/6/2310-K1The industry and the markets in which the Company operates are highly competitive and subject to rapid technological change
1/29/24424B51Underwriting
2/13/2410-Q1Unregistered Sales of Equity Securities and Use of Proceeds
9/6/2310-K1Unresolved Staff Comments
1/29/24424B51Use of Proceeds
9/18/23DEF 14A1Voting Methods
1/29/24424B51Where You Can Find More Information
9/18/23DEF 14A1Who May Vote

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 9:44:38.2pm ET